Have a personal or library account? Click to login
Prevalence of Vitamin D Deficiency Among Patients After Kidney Transplantation in Latvia Cover
Open Access
|Jun 2013

References

  1. Anonymous (2003). National Kidney Foundation/KDOQI clinical practice guidelines. Guideline 7 in bone metabolism and disease in chronic kidney disease. Amer. J. Kidney Dis., 42 (Suppl 3), S1-S201.
  2. Anonymous (2009). KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder. Kidney Int., 76 (Suppl 113), S1-S130.
  3. Badr, W., Martin, K., J. (2008). Vitamin D and kidney disease. Clin. J. Amer. Soc. Nephrol., 3 (5), 1555-1560.10.2215/CJN.01150308457114318450926
  4. Bischoff-Ferrari, H. A., Dawson-Hughes, B., Willett, W. C., Staehelin, H. B., Bazemore, M. G., Zee, R. Y., Wong, J. B. (2004). Effect of Vitamin D on falls: A meta-analysis. J.A.M.A., 291 (16), 1999-2006.10.1001/jama.291.16.199915113819
  5. Boudville, N. C., Hodsman, A. B. (2006). Renal function and 25-hydroxyvitaminDconcentrations predict parathyroid hormone levels in renal transplant patients. Nephrol. Dial. Transplant., 21 (9), 2621-2624.10.1093/ndt/gfl20116644777
  6. Chapuy, M. C., Preziosi, P., Maamer, M., Arnaud, S., Galan, P., Hercberg, S., Meunier, P. J. (1997). Prevalence of vitamin D insufficiency in an adult normal population. Osteoporos. Int., 7 (5), 439-443.10.1007/s0019800500309425501
  7. Cheng, S., Coyne, D. (2007). Vitamin D and outcomes in chronic kidney disease. Curr. Opin. Nephrol. Hypertens., 16 (2), 77-82.10.1097/MNH.0b013e32802ef49417293681
  8. Cunningham, J., Makin, H. (1997). How important is vitaminDdeficiency in uraemia. Nephrol. Dial. Transplant., 12 (1), 16-18.10.1093/ndt/12.1.169027765
  9. Dawson-Huges, B., Heaney, R. P., Holick, M. F., Lips, P., Meunier, P. J., Vieth, R. (2005). Estimates of optimal vitamin D status. Osteoporos. Int.,16 (7), 713-716.10.1007/s00198-005-1867-715776217
  10. Drechsler, C., Verduijn, M., Pilz, S., Dekker, F. W., Krediet, R. T., Ritz, E., Wanner, C., Boeschoten, E. W., Brandenburg, V.; NECOSAD Study Group. (2011). Vitamin D status and clinical outcomes in incident dialysis patients: Results from the NECOSAD study. Nephrol. Dial. Transplant.,26 (3), 1024-1032.10.1093/ndt/gfq60620947538
  11. Ewers, B., Gasbjerg, B., Moelgaard, C., Frederiksen, A., Marckmann P. (2008). Vitamin D status in kidney transplant patients: Need for intensified routine supplementation. Amer. J. Clin. Nutr., 87 (2), 431-437.10.1093/ajcn/87.2.43118258635
  12. Fleseriu, M., Licata, A. A. (2007). Failure of successful renal transplant to produce appropriate levels of 1,25-dihydroxyvitamin D. Osteoporos. Int.,18 (3), 363-368.10.1007/s00198-006-0238-317061149
  13. Ghazali, A., Fardellone, P., Pruna, A., Atik, A., Achard, J. M., Oprisiu, R., Brazier, M., Remond, A., Morinière, P., Garabedian, M., Eastwood, J., Fournier, A. (1999). Is low plasma 25-(OH)vitamin D a major risk factor for hyperparathyroidism and Looser's zones independent of calcitriol. KidneyInt., 55 (6), 2169-2177.10.1046/j.1523-1755.1999.00480.x10354266
  14. Gonzalez, E. A., Sachdeva, A., Oliver, D. A., Martin, K. J. (2004). VitaminD insufficiency and deficiency in chronic kidney disease. A single center observational study. Amer. J. Nephrol., 24 (5), 503-510.
  15. Grant, W. B. (2002a). An ecologic study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer, 94 (6), 272-281.10.1002/cncr.1019611815987
  16. Grant, W.B. (2002b). An estimate of premature cancer mortality in the U.S. due to inadequate doses of solar ultraviolet-B radiation. Cancer, 94 (6), 1867-1875.10.1002/cncr.1042711920550
  17. Hanley, D. A., Davison, K. S. (2005). Vitamin D insufficiency in North America. J. Nutr., 135 (2), 332-337.10.1093/jn/135.2.33215671237
  18. Heaney, R. P. (2008). Vitamin D in health and disease. Clin. J. Amer. Soc. Nephrol., 3 (5),1535-1541.10.2215/CJN.01160308457114618525006
  19. Hirani, V., Tull, K., Ali, A., Mindell, J. (2010). Urgent action needed to improve vitamin D status among older people in England! Age Ageing, 39 (1), 62-68.10.1093/ageing/afp19519934073
  20. Holick, M. F. (2004). Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Amer. J. Clin. Nutr., 80 (6 Suppl), 1678S-88S.10.1093/ajcn/80.6.1678S15585788
  21. Holick, M. F. (2007). Vitamin D deficiency. New Engl. J. Med., 357, 266-281.10.1056/NEJMra07055317634462
  22. Hollis, B. W. (1996). Assessment of vitamin D nutritional and hormonal status: What to measure and how to do it. Calcif. Tissue Int., 58 (1), 4-5.10.1007/BF025095388825231
  23. Hollis, B. W., Wagner, C. L., Drezner, M. K., Binkley, N. C. (2007). Circulating vitamin D(3) and 25-hydroxyvitamin D in humans: An important tool to define adequate nutritional vitamin D status. J. Steroid Biochem. Mol. Biol., 103 (3-5), 631-634.10.1016/j.jsbmb.2006.12.066186855717218096
  24. Jean, G., Charra, B., Chazot, C. (2008). Vitamin D deficiency and associated factors in hemodialysis patients. J. Ren. Nutr., 18 (5), 395-399.10.1053/j.jrn.2008.04.003
  25. Jones, G. (2007). Expanding role of vitamin D in chronic kidney disease: Importance of blood 25-OH-D levels and extra-renal 1a-hydroxylase in the classical and nonclassical actions of 1a,25-dihydroxyvitamin D3. Seminarsin Dialysis, 20 (4), 316-324.10.1111/j.1525-139X.2007.00302.x
  26. Kokado, Y. (2006). Kidney transplantation: prevention and treatment for bone loss after transplantation. Clin. Calcium, 16 (1), 86-91.
  27. LaClair, R. E., Hellman, R. N., Karp, S. L., Kraus, M., Ofner, S., Li, Q., Graves, K. L., Moe, S. M. (2005). Prevalence of calcidiol deficiency in CKD:Across-sectional study across latitudes in the United States. Amer. J. Kidney Dis., 45 (6), 1026-1033.10.1053/j.ajkd.2005.02.029
  28. Lee, P., Eisman, J. A., Center, J. R. (2009). Vitamin D deficiency in critically ill patients. New Engl. J. Med., 360 (18), 1912-1914.10.1056/NEJMc0809996
  29. Lemire, J. M. (1995). Immunomodulatory actions of 1.25-dihydroxyvitamin D3. J. Steroid. Biochem. Mol. Biol., 53 (6), 599-602.10.1016/0960-0760(95)00106-A
  30. Lips, P. (2001). Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr. Rev., 22 (4): 477-501.
  31. Lips, P. (2007). Vitamin D status and nutrition in Europe and Asia. J. SteroidBiochem. Mol. Biol., 103 (3-5), 620-625.10.1016/j.jsbmb.2006.12.07617287117
  32. Lips, P., Hosking, D., Lippuner, K., Norquist, J. M., Wehren, L., Maalouf, G., Ragi-Eis, S., Chandler, J. (2006). The prevalence of vitamin D inadequacy amongst women with osteoporosis: An international epidemiological investigation. J. Intern. Med., 260 (3): 245-254.
  33. Lomonte, C., Antonelli, M., Vernaglione, L. (2005). Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients? J. Nephrol., 18 (1), 96-101.
  34. MacLaughlin, J., Holick, M. F. (1985). Aging decreases the capacity of human skin to produce vitamin D3. J. Clin. Invest., 76 (4), 1536-1538.10.1172/JCI1121344241232997282
  35. Marcen, R., Ponte, B., Rodriguez-Mendiola, N., Galeano, C., Villafruela, J. J., Teruel, J. L., Burgos, F. J., Ortuño, J. (2009a). Secondary hyperparathyroidism after kidney transplantation: A cross-sectional study. Transplant. Proc., 41 (6), 2391-2393.10.1016/j.transproceed.2009.06.04719715929
  36. Marcen, R., Ponte, B., Rodriguez-Mendiola, N., Galeano, C., Villafruela, J. J., Teruel, J. L., Burgos, F. J., Ortuño, J. (2009b). Vitamin D deficiency in kidney transplant recipients: Risk factors and effects of vitamin D3 supplements. Transplant. Proc., 41 (6), 2388-2390.10.1016/j.transproceed.2009.06.05019715928
  37. Matsuoka, L.Y., Ide, L., Wortsman, J., MacLaughlin, J. A., Holick, M. F. (1987). Sunscreens suppress cutaneous vitamin D3 synthesis. J. Clin. Endocrinol. Metab., 64 (6), 1165-1168.10.1210/jcem-64-6-11653033008
  38. Mehrotra, R., Kermah, D., Salusky, I., Wolf, M.,Thadhani, R., Chiu, Y. W., Martins, D., Adler, S., Norris, K. (2009). Chronic kidney disease, hypovitaminosis D and the mortality in United States. Kidney Int., 76 (9), 977-983.10.1038/ki.2009.288
  39. Meija, L., Ðitova, A., Zeltîte, R., Erdmane, D., Rafaels, R., Teibe, U., Lietuvietis, V., Lejnieks, A. (2010). Vitamin D intake and deficiency in men at risk of prostate cancer. Eur. Urol. Suppl., 9 (6), 536.10.1016/S1569-9056(10)61211-0
  40. Nigwekar, S.,U., Bhan, I., Thadhani, R. (2012). Ergocalciferol and cholecalciferol in CKD. Amer. J. Kidney Dis., 60 (6), 139-156.10.1053/j.ajkd.2011.12.03522560832
  41. Pilz, S., Iodice, S., Zittermann, A., Grant, W. B., Gandini, S. (2011). Vitamin D status and mortality risk in CKD: A meta-analysis of prospective studies. Amer. J. Kidney Dis., 58 (3), 374-382.10.1053/j.ajkd.2011.03.02021636193
  42. Querings, K., Girndt, M., Geisel, J., Georg, T., Tilgen, W., Reichrath, J. (2006). 25-hydroxyvitamin D deficiency in renal transplant recipients. J. Clin. Endocrinol. Metab., 91 (2), 526-529.10.1210/jc.2005-054716303843
  43. Querings, K., Reichrath, J. (2004).Aplea for the analysis of vitamin-D levels in patients under photoprotection, including patients with xeroderma pigmentosum (XP) and basal cell nevus syndrome (BCNS). CancerCauses Control, 15 (2), 219.
  44. Rasa, I., Âdamsone, I., Daukste, I., Pavliòa, I., Platkâjis, A., Vçtra, A., Zelèa, S. (2011). Osteoporozes diagnostikas, profilakses un ârstçðanas vadlînijasLatvijâ [Guidelines for the diagnosis, prevention and treatment of osteoporosis in Latvia]. Rîga: Latvijas osteoporozes un kaulu metabolo slimîbu asociâcija. 158 lpp. (in Latvian).
  45. Reinhardt, W., Bartelworth, H., Jockenhovel, F., Schmidt-Gayk, H., Witzke, O., Wagner, K., Heemann, U., W., Reinwein, D., Philipp, T., Mann, K. (1998). Sequential changes of biochemical bone parameters after kidney transplantation. Nephrol. Dial. Transplant., 13 (2), 436-442.10.1093/oxfordjournals.ndt.a0278439509459
  46. Segersten, U., Correa, P., Hewison, M., Hellman, P., Dralle, H., Carling, T., Akerström, G., Westin, G. (2002). 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J. Clin. Endocrinol. Metab., 87 (6), 2967-2972.
  47. Stavroulopoulos, A., Cassidy, M. J., Porter, C. J., Hosking, D. J., Roe, S. D. (2007). Vitamin D status in renal transplant recipients. Amer. J. Transplant.,7 (11), 2546-2552.10.1111/j.1600-6143.2007.01978.x17908281
  48. Taskapan, H., Wei, M., Oreopoulos, D. G. (2006). 25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int. Urol. Nephrol., 38 (2), 323-329.10.1007/s11255-006-0081-716868705
  49. Yetley, E. A. (2008). Assessing the vitamin D status of the US population. Amer. J. Clin. Nutr. , 88 (2), 558S-564S.10.1093/ajcn/88.2.558S18689402
DOI: https://doi.org/10.2478/prolas-2013-0007 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 35 - 41
Published on: Jun 8, 2013
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2013 Ināra Ādamsone, Inese Folkmane, Diāna Amerika, Rafails Rozentāls, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.